For people with non-valvular atrial fibrillation rivaroxaban is non-inferior to warfarin for preventing stroke or embolism, with no difference in the risk of clinically relevant bleeding.
Evid Based Med. 2012 Feb 18;
Authors: Sherwood M, Piccini JP
PMID: 22345038 [PubMed - as supplied by publisher]